# On-treatment PLAtelet Reactivity-guided Therapy Modification FOR ST-segment Elevation Myocardial Infarction

> **NCT01739556** · PHASE3 · TERMINATED · sponsor: **Clinical Centre of Serbia** · enrollment: 242 (actual)

## Conditions studied

- Acute ST-elevation Myocardial Infarction

## Interventions

- **DRUG:** Antiplatelet Regimen Modification (aspirin or ticagrelor)

## Key facts

- **NCT ID:** NCT01739556
- **Lead sponsor:** Clinical Centre of Serbia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-06
- **Primary completion:** 2018-01
- **Final completion:** 2018-01
- **Target enrollment:** 242 (ACTUAL)
- **Why stopped:** An interim analysis showed that there is no difference in the primary endpoint, given the small number of events in the groups examined.
- **Last updated:** 2018-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01739556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01739556, "On-treatment PLAtelet Reactivity-guided Therapy Modification FOR ST-segment Elevation Myocardial Infarction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01739556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*